Heterotopic Ossification (HO)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Heterotopic Ossification (HO) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT07024407

A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton.

This is an open-label study of andecaliximab in participants at risk of developing bone where bone should not be, such as in muscle, tendons, and other soft tis…

United States10 participantsStarted 2025-05-14

Treatment: Andecaliximab

All recent trials (11 shown)

Active — Not RecruitingPhase 3

NCT05394116

A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adul…

This study is researching an experimental drug called garetosmab. The study is focused on adult patients with fibrodysplasia ossificans progressiva (FOP). The…

United States, Australia +2 more63 participantsStarted 2022-11-21

Treatment: Garetosmab, Placebo

CompletedNot Applicable

NCT06064656

A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progr…

Primary Objective(s): * To describe the demographic characteristics of people living with FOP and a matched cohort of non-FOP people living in the United State…

United States131 participantsStarted 2023-06-29

Treatment: Non-Interventional

Heterotopic Ossification (HO)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton.

All recent trials (11 shown)

A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adul…

A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progr…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton.

All recent trials (11 shown)

A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adul…

A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progr…

Comparative Analysis of Radiotherapeutic and Medical Procedures for the Prophylaxis of Heterotopic Ossifications

Celebrex and HO Study

HO Prophylaxis Therapy for Distal Humerus Fractures

Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progress…

ESWT as a Treatment for Chronic NHO in TBI Patients

Activ C European Multicenter Study

Celecoxib for Primary Prophylaxis of Combat-Related Heterotopic Ossification

Naproxen for the Prevention of HO After Complex Elbow Trauma